{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:24:13Z","timestamp":1759937053611},"reference-count":19,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7883\/yoken.jjid.2016.360","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T22:10:03Z","timestamp":1488233403000},"page":"423-429","source":"Crossref","is-referenced-by-count":11,"title":["Clinical Study of New Tetravalent (Type A, B, E, and F) Botulinum Toxoid Vaccine Derived from M Toxin in Japan"],"prefix":"10.7883","volume":"70","author":[{"given":"Yasushi","family":"Torii","sequence":"first","affiliation":[{"name":"Department of Animal Science, Tokyo University of Agriculture"},{"name":"Graduate School of Medicine, Osaka University"},{"name":"The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nakaba","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine, Osaka University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Kohda","sequence":"additional","affiliation":[{"name":"Department of Veterinary Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Kozaki","sequence":"additional","affiliation":[{"name":"Department of Veterinary Sciences, Graduate School of Life and Environmental Sciences, Osaka Prefecture University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazunori","family":"Morokuma","sequence":"additional","affiliation":[{"name":"The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikane","family":"Horikawa","sequence":"additional","affiliation":[{"name":"The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ginnaga","sequence":"additional","affiliation":[{"name":"The Chemo-Sero-Therapeutic Research Institute (KAKETSUKEN)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"National Institute of Infectious Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohide","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Pharmaceuticals and Medical Devices Agency"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Sakaguchi G. <i>Clostridium botulinum<\/i> toxins. Pharmacol Ther. 1982;19:165-94.","DOI":"10.1016\/0163-7258(82)90061-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Barash JR, Arnon SS. A novel strain of <i>Clostridium botulinum<\/i> that produces type B and type H botulinum toxins. J Infect Dis. 2014;209:183-91.","DOI":"10.1093\/infdis\/jit449"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Sugii S, Sakaguchi G. Molecular construction of <i>Clostridium botulinum<\/i> type A toxins. Infect Immun. 1975;12:1262-70.","DOI":"10.1128\/IAI.12.6.1262-1270.1975"},{"key":"4","unstructured":"4. Centers for Disease Control and Prevention. Botulism in the United States, 1899-1998. Handbook for epidemiologists, clinicians, and laboratory workers. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 1998."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA. 2001;285:1059-70.","DOI":"10.1001\/jama.285.8.1059"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Casadevall A, Pirofski LA. The weapon potential of a microbe. Trends Microbiol. 2004;12:259-63.","DOI":"10.1016\/j.tim.2004.04.007"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kondo H, Kondo S, Murata R, et al. Antigenicity of <i>Clostridium botulinum<\/i> type-E formol toxoid. Jpn J Med Sci Biol. 1969;22:75-85.","DOI":"10.7883\/yoken1952.22.75"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Torii Y, Tokumaru Y, Kawaguchi S, et al. Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid. Vaccine. 2002;20:2556-61.","DOI":"10.1016\/S0264-410X(02)00157-3"},{"key":"9","unstructured":"9. Ministry of Health, Labour and Welfare. The Ethical Guidelines for Clinical Research (Public Notice No. 415). 2008."},{"key":"10","unstructured":"10. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. Guideline for Good Clinical Practice E6 (R1). ICH Harmonised Tripartite Guideline. 1996."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Sakaguchi G, Ohishi I, Kozaki S. Purification and oral toxicities of <i>Clostridium botulinum<\/i> progenitor toxins. In: Lewis GE, editor. Biomedical Aspects of Botulism. New York, NY: Academic Press; 1981. p. 21-34.","DOI":"10.1016\/B978-0-12-447180-1.50007-9"},{"key":"12","unstructured":"12. Ministry of Health, Labour and Welfare. Minimum Requirements for Biological Products. 2004."},{"key":"13","unstructured":"13. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use. Guideline for Clinical Safety Data Management, E2A. ICH Harmonised Tripartite Guideline. 2005."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Torii Y, Takahashi M, Ishida S, et al. Quantification of potency of neutralizing antibodies to botulinum toxin using compound muscle action potential (CMAP). Toxicon. 2010;55:662-5.","DOI":"10.1016\/j.toxicon.2009.09.004"},{"key":"15","unstructured":"15. Ginnaga A, Morokuma K, Aihara K, et al. Characterization and clinical study on the acellular pertussis vaccine produced by a combination of column purified pertussis toxin and filamentous hemagglutinin. Tokai J Exp Clin Med. 1988;13 Suppl:59-69."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Huang LM, Lee CY, Lin TY, et al. Responses to primary and a booster dose of acellular, component, and whole-cell pertussis vaccines initiated at 2 months of age. Vaccine. 1996;14:916-22.","DOI":"10.1016\/0264-410X(95)00257-2"},{"key":"17","unstructured":"17. Shiosaki K, Kino Y. Efficacy and safety of inactivated polio vaccine (3)-precipitate DPT-IPV vaccine (Quattrovac subcutaneous injection syringe). Syounika Rinnsyou 2012;65:2307-17. Japanese."},{"key":"18","unstructured":"18. Ministry of Health, Labour and Welfare. Side reaction report of DPT vaccines, side reaction by vaccination subcommittee record for the Health Sciences Council of the Ministry of Health, Labour and Welfare. Available at &lt;http:\/\/www.mhlw.go.jp\/file\/05-Shingikai-10601000-Daijinkanboukouseikagakuka-Kouseikagakuka\/0000077621_1.pdf&gt;. Accessed Jun 15, 2016. Japanese."},{"key":"19","unstructured":"19. Ellis RJ. Immunobiologic agents and drugs available from the Centers for Disease Control: descriptions, recommendations, adverse reactions, and serologic response. 3rd edn. Atlanta, GA: Centers for Disease Control; 1982."}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/4\/70_JJID.2016.360\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T05:03:25Z","timestamp":1601701405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/4\/70_JJID.2016.360\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2016.360","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}